|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 110.20 HKD | -0.81% |
|
+2.70% | -2.48% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Biological Products | |||||||
Research, Development, Production and Sale of Biopharmaceutical Products | - | 23Cr | 84Cr | 452.63Cr | 212.39Cr | ||
Total Assets | 385.62Cr | 480.58Cr | 549.59Cr | 918.11Cr | 1.28TCr | ||
Interest Expense | -79.87L | -1.04Cr | -4.33Cr | -8.7Cr | -6.83Cr | ||
Income Tax Expense | - | - | - | 2L | - | ||
CAPEX | -45Cr | -72Cr | -80Cr | -72Cr | -59Cr | ||
EBT | -132.06Cr | -125.81Cr | -142.22Cr | 194.25Cr | -50Cr | ||
Gross Profit | - | 19Cr | 74Cr | 439.3Cr | 183.49Cr | ||
D&A | 2.17Cr | 5.7Cr | 10Cr | 14Cr | 19Cr | ||
Net Income | -117.71Cr | -107.49Cr | -116.84Cr | 202.83Cr | -51Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Mainland China | - | 9.7Cr | 84Cr | 159.35Cr | 187.8Cr | ||
Total Assets | 85Cr | 165.23Cr | 242.7Cr | 319.88Cr | 364.85Cr | ||
United States of America (USA) | - | 13Cr | - | 293.15Cr | 24Cr | ||
Total Assets | 1L | - | - | 29Cr | 40Cr | ||
Total Assets | 19.3L | - | - | - | - | ||
Other Regions | - | - | - | 12.03L | 22.56L | ||
Total Assets | 31T | 12.46L | 5L | 39T | 18T |
- Stock Market
- Equities
- 9926 Stock
- Financials Akeso, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition